These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 445468)

  • 1. Models for development of nonreceptor methods for distinguishing androgen-sensitive and -insensitive prostatic tumors.
    Isaacs JT; Isaacs WB; Coffey DS
    Cancer Res; 1979 Jul; 39(7 Pt 1):2652-9. PubMed ID: 445468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal models of the hormone-sensitive and -insensitive prostatic adenocarcinomas, Dunning R-3327-H, R-3327-HI, and R-3327-AT.
    Isaacs JT; Heston WD; Weissman RM; Coffey DS
    Cancer Res; 1978 Nov; 38(11 Pt 2):4353-9. PubMed ID: 698976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal and estrogen-stimulated hormone receptor profiles in four R3327 rat prostatic carcinoma sublines in relation to histopathology and androgen sensitivity.
    Mobbs BG; Johnson IE
    Cancer Res; 1988 Jun; 48(11):3077-83. PubMed ID: 3259159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of complete versus partial androgen withdrawal therapy for the treatment of prostatic cancer as studied in the Dunning R-3327 system of rat prostatic adenocarcinomas.
    Ellis WJ; Isaacs JT
    Cancer Res; 1985 Dec; 45(12 Pt 1):6041-50. PubMed ID: 4063963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unusual androgen sensitivity of the androgen-independent Dunning R-3327-G rat prostatic adenocarcinoma: androgen effect on tumor cell loss.
    Humphries JE; Isaacs JT
    Cancer Res; 1982 Aug; 42(8):3148-56. PubMed ID: 7093958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic instability coupled to clonal selection as a mechanism for tumor progression in the Dunning R-3327 rat prostatic adenocarcinoma system.
    Isaacs JT; Wake N; Coffey DS; Sandberg AA
    Cancer Res; 1982 Jun; 42(6):2353-71. PubMed ID: 7074614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of acid phosphatase from Dunning R3327H prostatic adenocarcinoma.
    Lee C; Murphy GP; Chu TM
    Cancer Res; 1980 Apr; 40(4):1245-8. PubMed ID: 7357554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
    Brändström A; Westin P; Bergh A; Cajander S; Damber JE
    Cancer Res; 1994 Jul; 54(13):3594-601. PubMed ID: 8012987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of androgen receptor levels to androgen responsiveness in the Dunning R3327 rat prostate tumor sublines.
    Diamond DA; Barrack ER
    J Urol; 1984 Oct; 132(4):821-7. PubMed ID: 6471235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of E-cadherin in the progression of rat prostatic cancer.
    Bussemakers MJ; van Moorselaar RJ; Giroldi LA; Ichikawa T; Isaacs JT; Takeichi M; Debruyne FM; Schalken JA
    Cancer Res; 1992 May; 52(10):2916-22. PubMed ID: 1581909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma.
    Isaacs JT; Coffey DS
    Cancer Res; 1981 Dec; 41(12 Pt 1):5070-5. PubMed ID: 7307008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and localization of androgen receptor in the R-3327 Dunning rat prostatic adenocarcinoma.
    Quarmby VE; Beckman WC; Cooke DB; Lubahn DB; Joseph DR; Wilson EM; French FS
    Cancer Res; 1990 Feb; 50(3):735-9. PubMed ID: 2404576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with an animal model for the study of prostatic carcinoma.
    Lubaroff DM; Culp DA
    Trans Am Assoc Genitourin Surg; 1977; 69():72-7. PubMed ID: 617916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of two sublines derived from rat prostatic adenocarcinoma (Dunning R 3327 tumor).
    Minagawa H; Miyauchi T; Wakisaka M; Fuse H; Matsuzaki O; Shimazaki J
    Gan; 1983 Aug; 74(4):524-33. PubMed ID: 6195040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concepts in prostatic cancer biology: Dunning R-3327 H, HI, and AT tumors.
    Isaacs JT; Weissman RM; Coffey DS; Scott WW
    Prog Clin Biol Res; 1980; 37():311-23. PubMed ID: 7384091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive activation of the 41- and 43-kDa mitogen-activated protein (MAP) kinases in the progression of prostate cancer to an androgen-independent state.
    Oka H; Chatani Y; Kohno M; Kawakita M; Ogawa O
    Int J Urol; 2005 Oct; 12(10):899-905. PubMed ID: 16323984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of soluble protein kinases from normal rat prostates and prostatic Dunning tumors.
    Chung LW; Breitweiser K
    Cancer Res; 1983 Jul; 43(7):3297-304. PubMed ID: 6303579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between tumor size and curability of prostatic cancer by combined chemo-hormonal therapy in rats.
    Isaacs JT
    Cancer Res; 1989 Nov; 49(22):6290-4. PubMed ID: 2804976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The characterization of a newly identified, highly metastatic variety of Dunning R 3327 rat prostatic adenocarcinoma system: the MAT LyLu tumor.
    Isaacs JT; Yu GW; Coffey DS
    Invest Urol; 1981 Jul; 19(1):20-3. PubMed ID: 7251319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic potential prediction by a visual grading system of cell motility: prospective validation in the Dunning R-3327 prostatic adenocarcinoma model.
    Mohler JL; Partin AW; Isaacs JT; Coffey DS
    Cancer Res; 1988 Aug; 48(15):4312-7. PubMed ID: 3390827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.